Search

Current filters: Treatment, Hepatitis C drugs, Hepatitis C

Common hepatitis C drugs available in Canada for adults

2018, CATIE
Tool - Webpage

Sofosbuvir + velpatasvir + voxilaprevir (Vosevi) for people with genotypes 1, 2 or 3 whose previous treatment failed

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir + voxilaprevir (Vosevi) for HCV re-treatment

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Glecaprevir + pibrentasvir (Maviret)—highly effective against genotype 3

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Safety and efficacy of glecaprevir + pibrentasvir (Maviret) in cases of liver or kidney transplant with chronic HCV infection

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Glecaprevir + pibrentasvir (Maviret) in HCV genotype 1 or 4 with previous treatment failure

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Know your drugs and classes of HCV treatment

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Better blood sugar control in people with diabetes after HCV has been cured

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Improvements in mood and energy after successful HCV treatments

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

New treatments for hepatitis C virus (HCV) to get approved in Canada later this year

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage